Life Cycle Investment Partners Ltd Makes New $374.04 Million Investment in HCA Healthcare, Inc. $HCA

Life Cycle Investment Partners Ltd bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 801,177 shares of the company’s stock, valued at approximately $374,037,000. HCA Healthcare comprises 2.6% of Life Cycle Investment Partners Ltd’s holdings, making the stock its 11th biggest position. Life Cycle Investment Partners Ltd owned 0.35% of HCA Healthcare as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $1,021,000. NewEdge Advisors LLC boosted its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the last quarter. Jump Financial LLC bought a new position in HCA Healthcare during the second quarter worth $2,073,000. Finally, Sei Investments Co. lifted its stake in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on HCA shares. Stephens reduced their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Barclays reduced their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Truist Financial lowered their target price on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday, April 27th. Weiss Ratings lowered HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, May 18th. Finally, Leerink Partners dropped their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The business’s fifty day moving average price is $465.16 and its two-hundred day moving average price is $483.61. The firm has a market capitalization of $87.49 billion, a PE ratio of 13.56, a P/E/G ratio of 1.25 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the business earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.